Targeting cannabinoid receptor 1 for multiple sclerosis: molecular docking and dynamic insights of berberine and curcumin as potential therapeutic agents
Targeting Cannabinoid Receptor 1 The cannabinoid receptor 1 (CB1) is a critical component of the endocannabinoid system, predominantly found in […]
